Risk-Based Decision Making integrates risk assessment into business processes, investment evaluations, product development, and strategic planning rather than treating risk as a separate compliance activity. Decision-makers weigh expected returns against potential losses, considering risk appetite and tolerance boundaries. This approach improves resource efficiency by focusing attention on high-risk areas while reducing unnecessary controls on low-risk activities. A pharmaceutical company uses risk-based decision making to prioritize drug development pipelines, balancing clinical success probability, market potential, and regulatory approval risks. Successful implementation requires accessible risk data, clear decision criteria, and a culture where discussing risks is encouraged rather than penalized.